日本人2型糖尿病患者を対象としたLY3209590の研究

基本情報

NCT ID: NCT03603704
ステータス: 完了
試験のフェーズ: 第1相
試験タイプ: 介入
目標被験者数: 31
治験依頼者名: Eli Lilly and Company

概要

The main purpose of this study is to evaluate the safety of a study drug known as LY3209590 in Japanese participants with type 2 diabetes. Side effects and tolerability will be documented. Blood samples will be taken to compare how the body handles the drug and how it affects blood sugar levels. The study will last about four weeks, not including screening. Screening is required within 4 weeks before the start of the study.

対象疾患

Diabetes Mellitus, Type 2

介入

LY3209590(DRUG)

Placebo(DRUG)

依頼者（Sponsor）

日本イーライリリー株式会社(INDUSTRY)

実施施設 (3)

博多診療所

Fukuoka, Japan

医療法人　住田病院

Sumida-ku, Tokyo, Japan

P-one clinic

Hachiōji, Tokyo, Japan